Precision Neuroscience is at the forefront of developing innovative brain-computer interface (BCI) technology aimed at restoring communication and independence for individuals with neurological conditions. Founded in 2021, the company has rapidly advanced its pioneering brain implant technology, securing over $155 million in funding and initiating human trials in collaboration with leading hospitals. With a multidisciplinary team of experts in neurosurgery, artificial intelligence, and engineering, Precision is dedicated to transforming scientific breakthroughs into practical solutions for those affected by conditions such as spinal cord injury, stroke, and ALS. The company fosters an inclusive culture that values diversity and is committed to driving innovation in the neurotechnology field.